GENECAPS Trademark

Trademark Overview


On Thursday, April 21, 2022, a trademark application was filed for GENECAPS with the United States Patent and Trademark Office. The USPTO has given the GENECAPS trademark a serial number of 97373693. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Wednesday, May 15, 2024. This trademark is owned by CSL Behring Gene Therapy, Inc.. The GENECAPS trademark is filed in the Pharmaceutical Products category with the following description:

Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

General Information


Serial Number97373693
Word MarkGENECAPS
Filing DateThursday, April 21, 2022
Status730 - FIRST EXTENSION - GRANTED
Status DateWednesday, May 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesNon-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Pseudo MarkGENE CAPS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCSL Behring Gene Therapy, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPasadena, CA 91101

Party NameCSL Behring Gene Therapy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPasadena, CA 91101

Trademark Events


Event DateEvent Description
Monday, April 25, 2022NEW APPLICATION ENTERED
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 8, 2023ASSIGNED TO EXAMINER
Wednesday, February 22, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 22, 2023NON-FINAL ACTION E-MAILED
Wednesday, February 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, August 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 22, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 15, 2024SOU EXTENSION 1 GRANTED
Wednesday, May 15, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 15, 2024SOU EXTENSION 1 FILED
Thursday, May 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 19, 2024SOU TEAS EXTENSION RECEIVED